Growth arrest-specific gene 6 (GAS6)

Summary

GAS6 (growth arrest-specific 6) belongs structurally to the family of plasma vitamin K-dependent proteins. GAS6 has a high structural homology with the natural anticoagulant protein S, sharing the same modular composition and having 40% sequence identity. Despite this, the low concentration of GAS6 in plasma and the pattern of tissue expression of GAS6 suggest a distinct function among vitamin-K dependent proteins. Indeed, GAS6 has growth factor-like properties through its interaction with receptor tyrosine kinases of the TAM family; Tyro3, Axl and MerTK. GAS6 employs a unique mechanism of action, interacting through its vitamin K-dependent GLA (γ-carboxyglutamic acid) module with phosphatidylserine-containing membranes and through its carboxy-terminal LamG domains with the TAM membrane receptors. During the last years there has been a considerable expansion of our knowledge of the biology of TAM receptors that has lead to a clear picture of their importance in inflammation, haemostasis and cancer, making this system an interesting target in biomedicine. The innate immune response and the coagulation cascade have been shown to be interconnected. Mediators of inflammation are essential in the initiation and propagation of the coagulation cascade, while natural anticoagulants have important anti-inflammatory functions. GAS6 represents a new player in this context, while protein S seems to have new functions beyond its anticoagulant role through its interaction with TAM receptors.

Keywords

Vitamin K - growth factors - innate immunity - inflammation - receptor tyrosine kinases - GLA

^* Present address: Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA

• References

• 1 Manfioletti G, Brancolini C, Avanzi G. et al. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993; 13: 4976-4985.
• 2 Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988; 54: 787-793.
• 3 Garcia de Frutos P, Fuentes-Prior P, Hurtado B. et al. Molecular basis of protein S deficiency. Thromb Haemost 2007; 98: 543-556.
• 4 Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008; 08: 327-336.
• 5 Kulman JD, Harris JE, Nakazawa N. et al. Vitamin K-dependent proteins in Ciona intestinalis, a basal chordate lacking a blood coagulation cascade. Proc Natl Acad Sci USA 2006; 103: 15794-15799.
• 6 Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost 2005; 03: 2633-2648.
• 7 Dahlback B, Lundwall A, Stenflo J. Localization of thrombin cleavage sites in the amino-terminal region of bovine protein S. J Biol Chem 1986; 261: 5111-5115.
• 8 Long GL, Lu D, Xie RL. et al. Human protein S cleavage and inactivation by coagulation factor Xa. J Biol Chem 1998; 273: 11521-11526.
• 9 Evenas P, Garcia de Frutos P, Nicolaes GA. et al. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thromb Haemost 2000; 84: 271-277.
• 10 He X, Shen L, Villoutreix BO. et al. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem 1998; 273: 27449-27458.
• 11 Giri TK, Villoutreix BO, Wallqvist A. et al. Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling. Thromb Haemost 1998; 80: 798-804.
• 12 Drakenberg T, Ghasriani H, Thulin E. et al. Solution structure of the Ca2+-Binding EGF3–4 pair from vitamin K-dependent protein S: identification of an unusual fold in EGF3. Biochemistry 2005; 44: 8782-8789.
• 13 Sasaki T, Knyazev PG, Clout NJ. et al. Structural basis for Gas6-Axl signalling. EMBO J 2006; 25: 80-87.
• 14 Harrison D, Hussain SA, Combs AC. et al. Crystal structure and cell surface anchorage sites of laminin alpha1LG4–5. J Biol Chem 2007; 282: 11573-11581.
• 15 Bellido-Martin L, Garcia de Frutos P. Vitamin K-dependent actions of Gas6. Vitam Horm 2008; 78: 185-209.
• 16 Nakano T, Higashino K, Kikuchi N. et al. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem 1995; 270: 5702-5705.
• 17 O’Donnell K, Harkes IC, Dougherty L. et al. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 1999; 154: 1171-1180.
• 18 Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 1996; 12: 471-480.
• 19 Melaragno MG, Cavet ME, Yan C. et al. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt. J Mol Cell Cardiol 2004; 37: 881-887.
• 20 Loeser RF, Varnum BC, Carlson CS. et al. Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage. Arthritis Rheum 1997; 40: 1455-1465.
• 21 Allen MP, Zeng C, Schneider K. et al. Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol 1999; 13: 191-201.
• 22 Yagami T, Ueda K, Asakura K. et al. Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology 2002; 43: 1289-1296.
• 23 Shankar SL, O’Guin K, Cammer M. et al. The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphati-dylinositol 3-kinase-dependent pathway. J Neurosci 2003; 23: 4208-4218.
• 24 Valverde P, Obin MS, Taylor A. Role of Gas6/Axl signaling in lens epithelial cell proliferation and survival. Exp Eye Res 2004; 78: 27-37.
• 25 Bellosta P, Zhang Q, Goff SP. et al. Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene 1997; 15: 2387-2397.
• 26 Shankar SL, O’Guin K, Kim M. et al. Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/ Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis. J Neurosci 2006; 26: 5638-5648.
• 27 Varnum BC, Young C, Elliott G. et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 1995; 373: 623-626.
• 28 Stitt TN, Conn G, Gore M. et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995; 80: 661-670.
• 29 Godowski PJ, Mark MR, Chen J. et al. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995; 82: 355-358.
• 30 Nyberg P, He X, Hardig Y. et al. Stimulation of Sky tyrosine phosphorylation by bovine protein S--domains involved in the receptor-ligand interaction. Eur J Biochem 1997; 246: 147-154.
• 31 Evenas P, Dahlback B, Garcia de Frutos P. The first laminin G-type domain in the SHBG-like region of protein S contains residues essential for activation of the receptor tyrosine kinase sky. Biol Chem 2000; 381: 199-209.
• 32 Garcia de Frutos P, Alim RI, Hardig Y. et al. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-822.
• 33 Giri TK, Linse S, Garcia de Frutos P. et al. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein. J Biol Chem 2002; 277: 15099-15106.
• 34 Evenas P, Garcia de Frutos P, Linse S. et al. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem 1999; 266: 935-942.
• 35 Rodriguez de Cordoba S, Perez-Blas M, Ramos-Ruiz R. et al. The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse. Genomics 1994; 21: 501-509.
• 36 Anderson HA, Maylock CA, Williams JA. et al. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003; 04: 87-91.
• 37 Wu Y, Tibrewal N, Birge RB. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol 2006; 16: 189-197.
• 38 Uehara H, Shacter E. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J Immunol 2008; 180: 2522-2530.
• 39 Prasad D, Rothlin CV, Burrola P. et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci 2006; 33: 96-108.
• 40 Hall MO, Obin MS, Heeb MJ. et al. Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Exp Eye Res 2005; 81: 581-591.
• 41 Karl MO, Kroeger W, Wimmers S. et al. Endogenous Gas6 and Ca(2+)-channel activation modulate phagocytosis by retinal pigment epithelium. Cell Signal 2008; 20: 1159-1168.
• 42 Hafizi S, Dahlback B. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev 2006; 17: 295-304.
• 43 Hasanbasic I, Cuerquis J, Varnum B. et al. Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H1207-1213.
• 44 Sawabu T, Seno H, Kawashima T. et al. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 2007; 46: 155-164.
• 45 Demarchi F, Verardo R, Varnum B. et al. Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem 2001; 276: 31738-31744.
• 46 Lee WP, Wen Y, Varnum B. et al. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis. Oncogene 2002; 21: 329-336.
• 47 Goruppi S, Ruaro E, Varnum B. et al. Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene 1999; 18: 4224-4236.
• 48 Weinger JG, Gohari P, Yan Y. et al. In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation. J Neurochem 2008; 106: 134-146.
• 49 Fridell YW, Jin Y, Quilliam LA. et al. Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol Cell Biol 1996; 16: 135-145.
• 50 Stenhoff J, Dahlback B, Hafizi S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochem Biophys Res Commun 2004; 319: 871-878.
• 51 Goruppi S, Ruaro E, Varnum B. et al. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol 1997; 17: 4442-4453.
• 52 Nielsen-Preiss SM, Allen MP, Xu M. et al. Adhesion related kinase induction of migration requires PI3-kinase and Ras stimulation of Rac activity in immortalized GnRH neuronal cells. Endocrinology 2007; 148: 2806-2814.
• 53 Todt JC, Hu B, Curtis JL. The receptor tyrosine kinase MerTK activates phospholipase C gamma2 during recognition of apoptotic thymocytes by murine macro-phages. J Leukoc Biol 2004; 75: 705-713.
• 54 Besser D, Bromberg JF, Darnell Jr. JE. et al. A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol 1999; 19: 1401-1409.
• 55 Yanagita M. The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology. Curr Opin Nephrol Hypertens 2004; 13: 465-470.
• 56 Lu Q, Gore M, Zhang Q. et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 1999; 398: 723-728.
• 57 Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001; 293: 306-311.
• 58 Wallet MA, Sen P, Flores RR. et al. MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med 2008; 205: 219-232.
• 59 Sen P, Wallet MA, Yi Z. et al. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 2007; 109: 653-660.
• 60 Seitz HM, Camenisch TD, Lemke G. et al. Macrophages and dendritic cells use different Axl/Mertk/ Tyro3 receptors in clearance of apoptotic cells. J Immunol 2007; 178: 5635-5642.
• 61 Lemke G, Lu Q. Macrophage regulation by Tyro 3 family receptors. Curr Opin Immunol 2003; 15: 31-36.
• 62 Cohen PL, Caricchio R, Abraham V. et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002; 196: 135-140.
• 63 Scott RS, McMahon EJ, Pop SM. et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 411: 207-211.
• 64 Camenisch TD, Koller BH, Earp HS. et al. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol 1999; 162: 3498-3503.
• 65 Grommes C, Lee CY, Wilkinson BL. et al. Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J Neuroimmune Pharmacol 2008; 03: 130-140.
• 66 Finnemann SC, Nandrot EE. MerTK activation during RPE phagocytosis in vivo requires alpha v beta 5 integrin. Retinal Degen Dis 2006; 572: 499-503.
• 67 Ishimoto Y, Ohashi K, Mizuno K. et al. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem (Tokyo) 2000; 127: 411-417.
• 68 Sather S, Kenyon KD, Lefkowitz JB. et al. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007; 109: 1026-1033.
• 69 Li Y, Gerbod-Giannone MC, Seitz H. et al. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J Biol Chem 2006; 281: 6707-6717.
• 70 Wu Y, Singh S, Georgescu MM. et al. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci 2005; 118: 539-553.
• 71 Nandrot EE, Finnemann SC. Altered rhythm of photoreceptor outer segment phagocytosis in beta 5 integrin knockout mice. Retinal Degen Dis 2006; 572: 119-123.
• 72 Rothlin CV, Ghosh S, Zuniga EI. et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007; 131: 1124-1136.
• 73 Sharif MN, Sosic D, Rothlin CV. et al. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006; 203: 1891-1901.
• 74 Hafizi S, Alindri F, Karlsson R. et al. Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin. Biochem Biophys Res Commun 2002; 299: 793-800.
• 75 Budagian V, Bulanova E, Orinska Z. et al. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J 2005; 24: 4260-4270.
• 76 Melaragno MG, Fridell YW, Berk BC. The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med 1999; 09: 250-253.
• 77 Konishi A, Aizawa T, Mohan A. et al. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem 2004; 279: 28766-28770.
• 78 Korshunov VA, Berk BC. Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol 2008; 15: 250-254.
• 79 Korshunov VA, Mohan AM, Georger MA. et al. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 2006; 98: 1446-1452.
• 80 Cavet ME, Smolock EM, Ozturk OH. et al. Gas6-Axl Receptor Signaling Is Regulated by Glucose in Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2008 in press.
• 81 Korshunov VA, Daul M, Massett MP. et al. Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension. Hypertension 2007; 50: 1057-1062.
• 82 D’Arcangelo D, Gaetano C, Capogrossi MC. Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res 2002; 91: e4-12.
• 83 Lutgens E, de Frutos PG, Aparicio C. et al. Gas6-/-/ApoE-/- mice develop a collagenrich, disorganized plaque phenotype, prone to intra-plaque hemorrhage. Circulation 2000; 102: 38.
• 84 Lutgens E, Tjwa M, de Frutos PG. et al. Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol. 2008 in press.
• 85 Collett GD, Sage AP, Kirton JP. et al. Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. Circ Res 2007; 100: 502-509.
• 86 Son BK, Kozaki K, Iijima K. et al. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol 2007; 556: 1-8.
• 87 Munoz X, Sumoy L, Ramirez-Lorca R. et al. Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Hum Mutat 2004; 23: 506-512.
• 88 Munoz X, Obach V, Hurtado B. et al. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost 2007; 98: 406-412.
• 89 Tjwa M, Bellido-Martin L, Lin Y. et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 2008; 111: 4096-4105.
• 90 Hasanbasic I, Rajotte I, Blostein M. The role of gamma-carboxylation in the anti-apoptotic function of gas6. J Thromb Haemost 2005; 03: 2790-2797.
• 91 Avanzi GC, Gallicchio M, Bottarel F. et al. GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 1998; 91: 2334-2340.
• 92 Balogh I, Hafizi S, Stenhoff J. et al. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 2005; 25: 1280-1286.
• 93 Borgel D, Clauser S, Bornstain C. et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006; 34: 219-222.
• 94 Alciato F, Sainaghi PP, Castello L. et al. Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J Immunoassay Immunochem 2008; 29: 167-180.
• 95 Gibot S, Massin F, Cravoisy A. et al. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 2007; 11: R8.
• 96 Clauser S, Peyrard S, Gaussem P. et al. Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status. Clin Chem 2007; 53: 1808-1813.
• 97 Garcia de Frutos P, Alim RI, Hardig Y. et al. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-822.
• 98 Angelillo-Scherrer A, Garcia de Frutos P, Aparicio C. et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001; 07: 215-221.
• 99 Saller F, Burnier L, Schapira M. et al. Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization. Blood Cells Mol Dis 2006; 36: 373-378.
• 100 Angelillo-Scherrer A, Burnier L, Flores N. et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 2005; 115: 237-246.
• 101 Chen C, Li Q, Darrow AL. et al. Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler Thromb Vasc Biol 2004; 24: 1118-1123.
• 102 Gould WR, Baxi SM, Schroeder R. et al. Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost 2005; 03: 733-741.
• 103 Wang H, Chen S, Chen Y. et al. The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis. Haematologica 2007; 92: 643-650.
• 104 Clauser S, Bachelot-Lozat C, Fontana P. et al. Physiological plasma Gas6 levels do not influence platelet aggregation. Arterioscler Thromb Vasc Biol 2006; 26: e22.
• 105 Burnier L, Borgel D, Angelillo-Scherrer A. et al. Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects. J Thromb Haemost 2006; 04: 2283-2284.
• 106 Brass LF, Zhu L, Stalker TJ. Novel therapeutic targets at the platelet vascular interface. Arterioscler Thromb Vasc Biol 2008; 28: s43-s50.
• 107 Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.